Computer Vision SyndromeNCT05699057
Tendency to Suicide as a Sequel of Computer Vision Syndrome
An observational study of Computer Vision Syndrome, run by Sohag University at 1 site in Egypt.
Trial summary
CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents Read more about this study
- Who is it for?
- Ages 16 years and older
- Conditions the study is for
- Computer Vision Syndrome
- What is being tested?
- Suicide GROUP
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 3,512 participants
- Where
- 1 siteEgypt
- Study dates
- 30 Oct 2022to 30 Mar 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- Child, Adult, Older adult
Study population: medical students or staff who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour, tendency to suicide and associated risk factor
Who may be able to join
- university students
- university staff members
Who cannot join
- hysteria
- ocular surgery
- amblyopia
- anisometropia
- strabismus
- systemic disease
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Prevalence and Associated Risk Factors of Tendency to Suicide as a Sequel of Computer Vision Syndrome Among Medical Students in Egypt
CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents
Read the detailed description
CVS-F4 (30 questions) will be an online survey via the SurveyMonkey Company. We will collect the responses and analyze the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. The questionnaire includes questions regarding potential ocular, extra-ocular, musclo-skeletal and neuro-psychatric complains caused by CVS. CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents Complete statistical analysis of the survey data will be done using univariate and multivariate logistic and linear regression analysis.
- Conditions
- Computer Vision Syndrome
- Being tested
- Suicide GROUP
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Suicide GROUPBehavioural
CVS-F4 will be an online survey via the SurveyMonkey Company. The participants will report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. We will collect the responses and analyse the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. This group will contain participants with CVS complains. Finally, we will To document the prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents.
What is being measured
The primary outcome is the main question the study is designed to answer.
Tendency to suicide
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentage of participants suffering from tendency to suicide will be recorded
Measured: 3 months
Depression
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentages of participants suffering from tendency to suicide and depression will be recorded. A correlation between depression and tendency to suicide will be measured as P value less than 0.05 will be significant
Measured: 3 months
Screen-time
The total daily average screen-hours will be measured using mean and standard deviation
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2023
- Study start30 Oct 2022
- Primary completion20 Feb 2023
- Study completion30 Mar 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Computer Vision SyndromeStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 3,512 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Prof. Mohammed Iqbal, Sohag University
- Investigators
- Mohammed Iqbal Iqbal, MD, PhD, Principal investigator, Professor of Ophthalmology
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05699057
- Sponsor's protocol ID
- Soh-Med-22-10-25
- Status last verified
- Mar 2023
- First submitted
- 9 Oct 2022
- Last updated
- 31 Mar 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The study data will available at the principal investigator for other researchers upon reasonable request after publication of the study
Study at a glance
From the registry record, last updated by the sponsor on 31 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence and Associated Risk Factors of Tendency to Suicide as a Sequel of Computer Vision Syndrome Among Medical Students in Egypt
- ClinicalTrials.gov ID
- NCT05699057
- Acronym / sponsor ID
- Soh-Med-22-10-25
- Conditions
- Computer Vision Syndrome
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 3,512 participants (actual)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 30 Oct 2022 (actual)
- Primary completion
- 20 Feb 2023 (actual)
- Study completion
- 30 Mar 2023 (actual)
- First posted
- 26 Jan 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents
Detailed description
CVS-F4 (30 questions) will be an online survey via the SurveyMonkey Company. We will collect the responses and analyze the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. The questionnaire includes questions regarding potential ocular, extra-ocular, musclo-skeletal and neuro-psychatric complains caused by CVS. CVS-F4 questionnaire will be used as an instrument to survey prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents Complete statistical analysis of the survey data will be done using univariate and multivariate logistic and linear regression analysis.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- medical students or staff who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour, tendency to suicide and associated risk factor
Key inclusion criteria (2 listed)
- university students
- university staff members
Key exclusion criteria (6 listed)
- hysteria
- ocular surgery
- amblyopia
- anisometropia
- strabismus
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Suicide GROUPCVS-F4 will be an online survey via the SurveyMonkey Company. The participants will report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. We will collect the responses and analyse the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. This group will contain participants with CVS complains. Finally, we will To document the prevalence of tendency to suicide among medical students in the Egyptian Universities and analyse associated risk factors and any correlated determents. | Behavioural | – |
Primary outcome
Tendency to suicide
Time frame: 3 months
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentage of participants suffering from tendency to suicide will be recorded
Depression
Time frame: 3 months
The participants will respond to Computer Vision Syndrome (CVS-F4) questionnaire and the number and percentages of participants suffering from tendency to suicide and depression will be recorded. A correlation between depression and tendency to suicide will be measured as P value less than 0.05 will be significant
Screen-time
Time frame: 3 months
The total daily average screen-hours will be measured using mean and standard deviation
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Mar 2023.
- Individual participant dataSharing planned: Yes. The study data will available at the principal investigator for other researchers upon reasonable request after publication of the study
Related trials for Computer Vision Syndrome
Not yet recruiting
Comparative Effects of Exercises on Pain, Cervical Proprioception, Neck Disability and Visual Performance in Patients With Computer Vision Syndrome.
Computer Vision Syndrome
Not yet recruiting
A Study of Full-Spectrum Screen Lighting for Reducing Screen-Related Eye Fatigue and Dry Eye
Visual Fatigue, Dry Eye
RecruitingObservational study
Longevity Metrics AI/ML Development Study
Aging, Mortality
Not yet recruitingObservational study
A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms
Extrapyramidal Symptoms, Drug-induced Parkinsonism
Not yet recruiting
AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial
Fibromyalgia, Fibromyalgia (FM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohammed Iqbal Iqbal, MD, PhD principal investigator
Professor of Ophthalmology
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Computer Vision Syndrome, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Tendency to suicide (time frame: 3 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2023.